Cognitive disorders in patients with a cardiological profile: diagnosis and prevention

Author:
E.K. Shavarova ^1.2 , A.A. Shavarov ¹ , R.E. Akhmetov ³ , railway Cobalava ^1.2

¹ FGAOU at the Russian University of Friendship of Peoples, Moscow, Russia;
² GBUZ "GKB named after V.V. Vinogradova DZM ”, Moscow, Russia;
³ LLC Scientific and Production Company "Pharmasoft", Moscow, Russia

Place of publication:
cardiology and cardiovascular surgery, 2022, T. 15, No. 6

Summary:
The development of preventive measures to reduce the risk of developing cognitive deficiency is named after the main priorities of medicine. Cardiovascular diseases and cognitive disorders, on the one hand, have similar risk factors, such as obesity, smoking, dyslipidemia, insufficient physical activity, low level of education, and, on the other hand, the presence of atrial fibrillation (FP), arterial hypertension (hypertension (hypertension ), heart failure (CH), chronic kidney disease, diabetes contributes to the progression of cognitive impairment. In the era of patient-oriented medicine, choosing the optimal treatment regimen of hypertension, FP, SN, it is necessary to take into account the potential possibilities of certain regimes of therapy in the prevention of cognitive impairment. This article is devoted to the review of existing therapeutic strategies to prevent the development of cognitive deficiency in patients with a cardiological profile. Keywords: cognitive disorders, dementia, arterial hypertension, atrial fibrillation, heart failure, Mexidol.